Clinical Use of Baytril in Canine and Feline Skin Infections

Usually, many factors inherent in skin infections and the difficulty identifying underlying diseases renders diagnosis and management of skin infections complex and time consuming. Canine and feline skin infections have a strong tendency to become chronic or recurrent, especially when inadequate antiinfective therapy is used.

In clinical cases where an underlying primary condition is suspected, systemic antiinfective therapy is always indicated.

Severe skin infections usually require an extended therapy regimen over several weeks. It is recommended to treat cases of superficial pyoderma for at least one week beyond the clinical cure of skin lesions. In patients with deep pyoderma, treatment should be maintained for at least two weeks after the visible lesions have resolved because sequestered foci of infection may still be present in deeper dermal regions (2).

Baytril has been clinically tested by dermatologists in several countries with consistent success rates of around 90%. Clinical studies on different types of dog pyoderma and dermatitis cases in cats have been published in several scientific papers.

PDF Version (Size: 782 KB)

© 2001 Bayer AG